Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

<br><strong>Background: </strong>Artemisinin and partner-drug resistance in Plasmodium falciparum are major threats to malaria control and elimination. Triple artemisinin-based combination therapies (TACTs), which combine existing co-formulated ACTs with a second partner drug that...

Full description

Bibliographic Details
Main Authors: Miotto, O, van der Pluijm, RW, Tripura, R, Hoglund, RM, Phyo, AP, Lek, D, ul Islam, A, Anvikar, AR, Satpathi, P, Satpathi, S, Behera, PK, Tripura, A, Baidya, S, Onyamboko, M, Chau, NH, Sovann, Y, Suon, S, Sreng, S, Mao, S, Oun, S, Yen, S, Amaratunga, C, Chutasmit, K, Saelow, C, Runcharern, R, Kaewmok, W, Hoa, NY, Thanh, NV, Hanboonkunupakarn, B, Callery, JJ, Mohanty, AK, Heaton, J, Thant, M, Gantait, K, Ghosh, T, Amato, R, Pearson, RD, Jacob, CG, Gonçalves, S, Mukaka, M, Waithira, N, Woodrow, CJ, Grobusch, MP, van Vugt, M, Fairhurst, RM, Cheah, PY, Peto, TJ, von Seidlein, L, Dhorda, M, Maude, RJ
Format: Journal article
Language:English
Published: Elsevier 2020

Similar Items